Asia Pacific Genome Editing Market by Application (Cell Line, Animal Genetic and Plant Genetic Engineering), by Technology (CRISPR, TALEN, ZFN, Antisense and Other Technologies), by End User (Biotechnological & Pharmaceutical Companies, Academic and Government Research Institutes and Contract Research Organizations), and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Asia Pacific Genome Editing Market by Application (Cell Line, Animal Genetic and Plant Genetic Engineering), by Technology (CRISPR, TALEN, ZFN, Antisense and Other Technologies), by End User (Biotechnological & Pharmaceutical Companies, Academic and Government Research Institutes and Contract Research Organizations), and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 2788 | Pages: 142 | August 2017 | Region: Asia Pacific


The Asia Pacific Genome Editing Market was worth USD 0.54 billion in 2016 and estimated to be growing at a CAGR of 15.66%, to reach USD 1.11 billion by 2021. Genome editing is a branch of genetic engineering in which DNA is inserted, deleted or replaced in the genome of a living organism with the aid of engineered nucleases which are otherwise known as molecular scissors. They work by creating site-specific double-strand breaks at the desired locations in the genome.

Genome Editing is used for research to understand the biology and inner workings of cells, to treat diseases such as modifying human blood cells to treat conditions such as leukaemia and AIDS. Other applications include in the field of biotechnology where it is used to modify crops to increase their yield and their resistance to diseases and drought. Another new application is genetically modifying cattle so as to develop them without horns.

The major factors affecting the Asia-Pacific Genome Editing market include the technological advancements with respect to the development of novel vectors used in genome editing and rising competition among operating companies to get a larger market share. Another driver for the market is the emerging interest in genome editing by pharmaceutical and biotechnological companies. Inspite of this, the toxicity due to off-target effects of nucleases is still a safety concern for the market. Additionally, the IP disputes related to use of CRISPR technology amongst the industry players is also expected to act as restraints for the market.

The Asia-Pacific Genome Editing market is broadly classified into Cell Line, Animal Genetic and Plant Genetic Engineering in the basis of application, by technology into CRISPR, TALEN, ZFN, Antisense and Other Technologies and on the basis of end user into Biotechnological & Pharmaceutical Companies, Academic and Government Research Institutes and Contract Research Organizations. Based on geography, the Asia-Pacific market is analysed under various regions namely India, China, Japan, South Korea and Australia. Asia-Pacific is expected to grow rapidly in the coming years as is evident from the high CAGR value for the region. This high growth rate can be attributed to the emerging economies of China and India. The region also has the third highest market share globally in addition to being the fastest growing market.

The Genome Editing market is highly competitive with a large number of players. Some of the major ones are Thermo Fisher Scientific, Merck KGAA, Horizon Discovery Group Plc, Genscript Biotech Corporation, Sangamo Biosciences, Integrated DNA Technologies, Lonza Group Ltd, New England Biolabs, Origene Technologies, and Transposagen Biopharmaceuticals.

  1. Introduction

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

  1. Research Methodology

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

  1. Overview

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemiology                             

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

  1. Market Segmentation

                5.1 Application                 

                                5.1.1 Introduction           

                                5.1.2 Cell Line Engineering           

                                5.1.3 Animal Genetic Engineering            

                                5.1.4 Plant Genetic Engineering

                                5.1.5 Y-o-Y Growth Analysis, By Application         

                                5.1.6 Market Attractiveness Analysis, By Application       

                                5.1.7 Market Share Analysis, By Application        

                5.2 Technology                 

                                5.3.1 Introduction           

                                5.3.2 CRISPR      

                                5.3.3 TALEN       

                                5.3.4 ZFN            

                                5.3.5 Antisense

                                5.3.6 Other Technologies             

                                5.3.7 Y-o-Y Growth Analysis, By Technology        

                                5.3.8 Market Attractiveness Analysis, By Technology      

                                5.3.9 Market Share Analysis, By Technology        

                5.3 End User                      

                                5.2.1 Introduction           

                                5.2.2 Biotechnological & Pharmaceutical Companies       

                                5.2.3 Academic and Government Research Institutes     

                                5.2.4 Contract Research Organizations   

                                5.2.5 Y-o-Y Growth Analysis, By End User             

                                5.2.6 Market Attractiveness Analysis, By End User           

                                5.2.7 Market Share Analysis, By End User             

  1. Geographical Analysis

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Application

                                                6.1.3.3 By Technology

                                                6.1.3.4 By End User

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Application

                                                6.1.4.3 By Technology

                                                6.1.4.4 By End User

                                6.1.5 Market Share Analysis       

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Application

                                                6.1.5.3 By Technology

                                                6.1.5.4 By End User

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

  1. Strategic Analysis

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five Analysis                             

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

  1. Market Leaders' Analysis

                8.1 Thermo Fisher Scientific                        

                                8.1.1 Overview 

                                8.1.2 Application Analysis            

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Merck KGAA                              

                8.3 Horizon Discovery Group Plc                               

                8.4 Genscript Biotech Corporation                           

                8.5 Sangamo Biosciences                             

                8.6 Integrated DNA Technologies                            

                8.7 Lonza Group Ltd                       

                8.8 New England Biolabs                              

                8.9 Origene Technologies                            

                8.10 Transposagen Biopharmaceuticals                 

  1. Competitive Landscape

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

  1. Market Outlook and Investment Opportunities

Appendix                                           

  1. a) List of Tables
  2. b) List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia Pacific Genome Editing Market Market By Application, From 2016-2021 ( USD Billion )
  2. Asia Pacific Cell Line Engineering Market By Region, From 2016-2021 ( USD Billion )
  3. Asia Pacific Animal Genetic Engineering Market By Region, From 2016-2021 ( USD Billion )
  4. Asia Pacific Plant Genetic Engineering Market By Region, From 2016-2021 ( USD Billion )
  5. Asia Pacific Genome Editing Market Market By Technology, From 2016-2021 ( USD Billion )
  6. Asia Pacific CRISPR Market By Region, From 2016-2021 ( USD Billion )
  7. Asia Pacific TALEN Market By Region, From 2016-2021 ( USD Billion )
  8. Asia Pacific ZFN Market By Region, From 2016-2021 ( USD Billion )
  9. Asia Pacific Antisense Market By Region, From 2016-2021 ( USD Billion )
  10. Asia Pacific Other Technologies Market By Region, From 2016-2021 ( USD Billion )
  11. Asia Pacific Genome Editing Market Market By End User, From 2016-2021 ( USD Billion )
  12. Asia Pacific Biotechnological & Pharmaceutical Companies Market By Region, From 2016-2021 ( USD Billion )
  13. Asia Pacific Academic and Government Research Institutes Market By Region, From 2016-2021 ( USD Billion )
  14. Asia Pacific Contract Research Organizations Market By Region, From 2016-2021 ( USD Billion )
  15. Japan Genome Editing Market Market By Application, From 2016-2021 ( USD Billion )
  16. Japan Genome Editing Market Market By Technology, From 2016-2021 ( USD Billion )
  17. Japan Genome Editing Market Market By End User, From 2016-2021 ( USD Billion )
  18. China Genome Editing Market Market By Application, From 2016-2021 ( USD Billion )
  19. China Genome Editing Market Market By Technology, From 2016-2021 ( USD Billion )
  20. China Genome Editing Market Market By End User, From 2016-2021 ( USD Billion )
  21. India Genome Editing Market Market By Application, From 2016-2021 ( USD Billion )
  22. India Genome Editing Market Market By Technology, From 2016-2021 ( USD Billion )
  23. India Genome Editing Market Market By End User, From 2016-2021 ( USD Billion )
  24. Australia Genome Editing Market Market By Application, From 2016-2021 ( USD Billion )
  25. Australia Genome Editing Market Market By Technology, From 2016-2021 ( USD Billion )
  26. Australia Genome Editing Market Market By End User, From 2016-2021 ( USD Billion )
  27. South Korea Genome Editing Market Market By Application, From 2016-2021 ( USD Billion )
  28. South Korea Genome Editing Market Market By Technology, From 2016-2021 ( USD Billion )
  29. South Korea Genome Editing Market Market By End User, From 2016-2021 ( USD Billion )
Middle East And Africa Rubella Vaccine Market By End User (Pediatric Rubella Vaccine, Adult Rubella Vaccine, And Traveler Rubella Vaccine), And Region -Industry Analysis, Size, Share, Growth, Trends, And Forecasts (...
Latin America Rubella Vaccine Market By End User (Pediatric Rubella Vaccine, Adult Rubella Vaccine, And Traveler Rubella Vaccine), And Region -Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017 To 2...
Asia Pacific Rubella Vaccine Market By End User (Pediatric Rubella Vaccine, Adult Rubella Vaccine, And Traveler Rubella Vaccine), And Region -Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017 To 20...
Europe Rubella Vaccine Market By End User (Pediatric Rubella Vaccine, Adult Rubella Vaccine, And Traveler Rubella Vaccine), And Region -Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017 To 2022)...
North America Rubella Vaccine Market By End User (Pediatric Rubella Vaccine, Adult Rubella Vaccine, And Traveler Rubella Vaccine), And Region -Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017 To 2...
Rubella Vaccine Market By End User (Pediatric Rubella Vaccine, Adult Rubella Vaccine, And Traveler Rubella Vaccine), And Region -Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017 To 2022)...
Middle-East And Africa Zika Virus Vaccines Market By Type (Therapeutic Vaccines, Preventive Vaccines), End-user (Hospitals, Clinics, Research Institutes, Others) And By Region - Industry Analysis, Size, Share, Growt...
Latin America Zika Virus Vaccines Market By Type (Therapeutic Vaccines, Preventive Vaccines), End-user (Hospitals, Clinics, Research Institutes, Others) And By Region - Industry Analysis, Size, Share, Growth, Trends...
Asia-Pacific Zika Virus Vaccines Market By Type (Therapeutic Vaccines, Preventive Vaccines), End-user (Hospitals, Clinics, Research Institutes, Others) And By Region - Industry Analysis, Size, Share, Growth, Trends,...
Europe Zika Virus Vaccines Market By Type (Therapeutic Vaccines, Preventive Vaccines), End-user (Hospitals, Clinics, Research Institutes, Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And F...
North America Zika Virus Vaccines Market By Type (Therapeutic Vaccines, Preventive Vaccines), End-user (Hospitals, Clinics, Research Institutes, Others) And By Region - Industry Analysis, Size, Share, Growth, Trends...
Zika Virus Vaccines Market By Type (Therapeutic Vaccines, Preventive Vaccines), End-user (Hospitals, Clinics, Research Institutes, Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And ...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.